Physician profile
Jonathon Michael Pullara
NPI 1851885511
$1,617.22
in general payments reported to CMS, 2019-2025
10 companies · $916 in 2025
The $916 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $102 · 2023: $380 · 2024: $220 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $577.35 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Depuy Synthes Sales INC. | $443.16 | 2023-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Globus Medical, INC. | $173.68 | 2025 | Harvest |
| Stryker Corporation | $136.11 | 2025 | Smartlock |
| Medical Device Business Services, INC. | $101.67 | 2022 | |
| Checkpoint Surgical, INC | $81.71 | 2023 | Checkpoint Stimulators |
| Acera Surgical, INC. | $42.30 | 2025 | Restrata Wound Matrix |
| Davol INC. | $24.15 | 2024 | Arista Ah Flexitip |
| Kerecis Limited | $19.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Straumann USA LLC | $17.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Pullara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.